Leading CBD company Charlotte's Web is climbing. Cannabis investors need to see why.
Opinion
Choom Stacks Its Management Team as Canadian Cannabis Heats Up
As Canada's cannabis retail sales take off and Phase 2 of legalization approaches, Choom has just added a heavy-hitter to its management.
The Next Wave of Canadian Cannabis Extraction Specialists
Canada's cannabis extraction leaders -- Valens and MediPharm -- have already produced strong returns for investors. Here are some additional names to look at in Canadian cannabis extraction.
California’s NEW ‘War on Drugs’
California is attacking its cannabis black market with a NEW War on Drugs. We've seen this movie before. It doesn't end well.
An Open Letter to Market Watch re: negative cannabis coverage
Market Watch's NEGATIVE July 26th article on the cannabis industry flies in the face of good news on both sides of the Border
California Cannabis Beverage Company Likes Canada’s Beverage Market
The 'grass is greener' in Canada for cannabis-infused beverages according to this California beverage manufacturer. Here's why.
Big Tobacco + Cannabis, A Marriage Made in Hell
Imperial Brands' CAD$123 million investment in Auxly Group is another tobacco/cannabis Deal-with-the-Devil
U.S. Cannabis Edibles: Billions of Revenue Dollars Today, $10’s of Billions Tomorrow
The future of cannabis edibles is extremely bright: $10's of billions potentially on the table. At this level of development, investors can still find strong value propositions.
Major Canadian Retailer Jumps Into Canadian Cannabis With Up To CAD$380 Million In Growth Capital
Couche-Tard, a $7.7B food retailing giant with 16,000 stores in 26 countries is committing up to CAD$380 million in capital to cannabis. Big news.
CBD-Rich Hemp Biomass: a NEW Profit Generator in the Cannabis Space
MYM's sale of CAD$25 million in CBD-rich hemp biomass has the Company on track to meet revenue/profit targets.
FDA Cracks Down on Curaleaf over CBD ‘Drugs’
Curaleaf is not allowed to sell many of its CBD products online. Why not? Because the FDA continues to get in the way.
Is It Too Soon To Get Into U.S. Cannabis Extraction?
With few public companies to choose from, one Oregon-based cannabis extraction specialist offers intriguing possibilities for investors.
Canada’s Cannabis Industry Turns The Corner
Canada's legal cannabis industry has recorded its 3rd consecutive month of double-digit sales growth. Sales should accelerate going forward. Higher valuations should follow.
Sign Of Coming Cannabis Stock Rally?: Why Flowr Corp Shares Are Soaring Today
Surprising news from Flowr Corp looks bad, but could signal a turnaround in cannabis stocks is near.
Is CBD Ready to Make its BIG Move in the U.S.?
The U.S. market for CBD-based products COULD reach $6 billion by 2025. Is the FDA about to get out of the way?